Skip to main content
European Radiology Experimental
Fig. 2 | European Radiology Experimental

Fig. 2

From: Multi-b-value DWI to evaluate the synergistic antiproliferation and anti-heterogeneity effects of bufalin plus sorafenib in an orthotopic HCC model

Fig. 2

Grayscale images of two whole hematoxylin-eosin -stained slides and corresponding histograms of pixel distribution after treatment. a Grayscale image of a tumor in the bufalin plus sorafenib treatment group (histopathological standard deviation 10.475). b Grayscale image of a tumor in the control group (histopathological standard deviation 13.795). c Histograms of pixel distributions in the grayscale images of the tumors in the bufalin plus sorafenib treatment (blue) and control groups (orange)

Back to article page